Imiglucerase (Cerezyme<sup>®</sup>) improves quality of life in patients with skeletal manifestations of Gaucher disease.
Weinreb, N.; Barranger, J.; Packman, S.; Prakash-Cheng, A.; Rosenbloom, B.; Sims, K.; Angell, J.; Skrinar, A.; Pastores, G. M.; Clinical Genetics, 2007, vol. 71, issue 6, p 576, ISSN 00099163. ISBN 00099163.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef